ULTRAPAR PARTICIPAÇÕES S.A.
SUMMARY VOTING MAPS RECEIVED FROM THE BOOKKEEPER
São Paulo, April 11, 2022 - Ultrapar Participações S.A. (B3: UGPA3 / NYSE: UGP,
"Company"), in compliance with CVM Instruction 481/02, as amended, hereby discloses to its shareholders and the market in general the summary voting maps received from the Company's bookkeeper for the Annual and Extraordinary General Shareholders' Meeting to be held on April 13, 2022.
Annual General Shareholders' Meeting - April 13, 2022 at 2:00 p.m.
Deliberation Vote Number of shares | ||
1. Analysis and approval of the report and accounts of the Management, as well as the financial statements of the fiscal year ended on December 31, 2021, together with the report from the Independent Auditors and the report from the Fiscal Council | Approve | 204,951,301 |
Reject | 200,000 | |
Abstain | 57,492,120 | |
2. Allocation of net income for the fiscal year ended on December 31, 2021 | Approve | 261,324,643 |
Reject | 1,318,778 | |
Abstain | - | |
3. Establishment of the Management's global compensation | Approve | 240,130,580 |
Reject | 21,745,544 | |
Abstain | 767,297 | |
4.a. Election of the members of the Fiscal Council and respective alternates, given the request for the installation of the Fiscal Council made by a shareholder representing more than 2% (two percent) of the voting shares issued by the Company. Appointment of the following candidates:
| Approve | 261,028,579 |
Reject | 883,035 | |
Abstain | 731,807 | |
4.b. Election of the members of the Fiscal Council and respective alternates, given the request for the installation of the Fiscal Council made by a shareholder representing more than 2% (two percent) of the voting shares issued by the Company. Appointment of the following candidates:
| Approve | 261,028,579 |
Reject | 883,035 | |
Abstain | 731,807 | |
4.c. Election of the members of the Fiscal Council and respective alternates, given the request for the installation of the Fiscal Council made by a shareholder representing more than 2% (two percent) of the voting shares issued by the Company. Appointment of the following candidates:
| Approve | 261,228,579 |
Reject | 683,035 | |
Abstain | 731,807 | |
5. Considering the item above, the establishment of the compensation of the members of the Fiscal Council for the term of office that begins in April 2022 | Approve | 260,882,596 |
Reject | - | |
Abstain | 1,760,825 |
Extraordinary General Shareholders' Meeting - April 13, 2022 at 2:00 p.m.
Deliberation Vote Number of shares | ||
1. Change of the number of members that integrate the Board of Directors | Approve | 261,927,564 |
Reject | 35,490 | |
Abstain | - |
2. Election of member of the Board of Directors | Approve | 253,034,269 |
Reject | 8,832,721 | |
Abstain | 96,064 |
3. Resolution on the following amendments to the Company's Bylaws as detailed in the Management Proposal: (a) change in the percentage of independent members of the Board of Directors | Approve | 261,963,054 |
Reject | - | |
Abstain | - |
3. Resolution on the following amendments to the Company's Bylaws as detailed in the Management Proposal: (b) change in the composition of the advisory committees of the Board of Directors | Approve | 261,963,054 |
Reject | - | |
Abstain | - |
3. Resolution on the following amendments to the Company's Bylaws as detailed in the Management Proposal: (c) adaptation of the statutory provisions applicable to the Audit and Risks Committee, in order to adapt it to the requirements of CVM Resolution 23/21 | Approve | 261,963,054 |
Reject | - | |
Abstain | - |
3. Resolution on the following amendments to the Company's Bylaws as detailed in the Management Proposal: (d) reduction of the percentage of net income to be allocated to the payment of mandatory dividends to shareholders, along with the consequent adjustment in the percentage to be allocated to the investment reserve | Approve | 261,963,054 |
Reject | - | |
Abstain | - |
4. Ratification on the change in the number of common shares into which the Company's capital stock is divided, due to the partial exercise of the rights conferred by the subscription warrants issued by the Company as of the approval of the merger of shares issued by Imifarma Produtos Farmacêuticos e Cosméticos S.A. by the Company, approved by the Extraordinary General Shareholders' Meeting held on January 31, 2014 | Approve | 261,963,054 |
Reject | - | |
Abstain | - |
5. Approval of the consolidation of the Bylaws, in order to reflect the changes proposed in the items above | Approve | 261,963,054 |
Reject | - | |
Abstain | - |
Rodrigo de Almeida Pizzinatto
Chief Financial and Investor Relations Officer
Ultrapar Participações S.A.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Ultrapar Participações SA published this content on 11 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 April 2022 22:00:08 UTC.